Clinicopathologic features of lymphoplasmacytic lymphoma

Chinese Journal of Pathology

Volumn 39, Issue 5, 2010, Pages 308-312

  Liu, En Bin ^a   Zhang, Pei Hong ^a   Li, Zhan Qi ^a   Sun, Qi ^a   Yang, Qing Ying ^a   Fang, Li Huan ^a   Sun, Fu Jun ^a   Qiu, Lu Gui ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Bone marrow diseases; Diagnosis, differential; Lymphoma, small lymphocytic; Waldenstrom macroglobulinemia

Indexed keywords

ANTINEOPLASTIC AGENT; CD20 ANTIGEN; CD38 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN LIGHT CHAIN; PAX5 PROTEIN, HUMAN; PREDNISONE; SYNDECAN 1; TRANSCRIPTION FACTOR PAX5; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER INVASION; CHRONIC LYMPHATIC LEUKEMIA; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; IMMUNOPHENOTYPING; LYMPH NODE; MALE; MARGINAL ZONE LYMPHOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; SPLEEN TUMOR; SURVIVAL RATE; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; ANTIGENS, CD20; ANTIGENS, CD38; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-CELL-SPECIFIC ACTIVATOR PROTEIN; BONE MARROW; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPH NODES; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PREDNISONE; SPLENIC NEOPLASMS; SURVIVAL RATE; SYNDECAN-1; VINCRISTINE; WALDENSTROM MACROGLOBULINEMIA;

EID: 77953093912     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2010.05.005     Document Type: Article

References (11)

1. Swerdlow SH, Berger F, Pileri SA, et al. Lymphoplasmacytic lymphoma//Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumours. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2008:194-195.
2. Viswanatha D, Foucar K. Hodgkin and non-Hodgkin lymphoma involving bone marrow. Semin Diagn Pathol, 2003, 20(3):196-210.
3. Treon SP, Hatjiharissi E, Leleu X, et al. Waldenström macroglobulinemia/Lymphoplasmacytic lymphoma//Hoffman R, Benzjr EJ, Shattil SJ, et al. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2008:1413-1423.
4. Lin P, Medeiros LJ. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: an evolving concept. Adv Anat Pathol, 2005, 12(5):246-255.
5. Brown D, Garter K, Natkunam Y, et al. Bone marrow diagnosis: an illustrated guide. Oxford: Blackwell Publishing, 2006:116-121.
6. Konoplev S, Medeiros J, Bueso-Ramos CE, et al. Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia. Am J Clin Pathol, 2005, 124(3):414-420.
7. Isaacson PG, Piris MA, Berger F, et al. Splenic B-cell marginal zone lymphoma//Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumours. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2008:185-187.
8. Mckenna RW, Kyle RA, Kuehl WM, et al. Plasma cell neoplasms//Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumours. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon; IARC Press, 2008:200-213.